Pfizer and Merck post modest results
May 6, 2010Sales and Marketing 2010 financials, Merck, Pfizer
The acquisition of Wyeth has added over $5 billion to Pfizer’s revenue buts its own sales fail to shine. Both …
Greece’s crisis could hit European prices
May 6, 2010Sales and Marketing Greece, industry, parallel trade, prices
GlaxoSmithKline’s chief executive Andrew Witty has warned that the economic crisis in Greece could have a knock-on effect across Europe, …
Sanofi signs Indian pain drug development deal
May 5, 2010Research and Development Glenmark, Sanofi-Aventis, chronic pain, pain therapeutics
Sanofi-Aventis has signed an agreement with Indian firm Glenmark Pharmaceuticals to develop novel agents for the treatment of chronic pain. …
Collaborative cancer drug project targets research efficiency
May 5, 2010Research and Development Animal testing, Animal tests, Cancer, biomarkers, clinical drug development
A new pharma-academia project being managed by the University of Dundee is setting its sights on improving the effectiveness of …
Digital Pharma: Online medical information influences treatment
May 5, 2010Medical Communications, Sales and Marketing Datapharm, digital patients, patient information
More than half of health searches in the UK result in treatment or management changes, according to new research by …
Virgo expands med ed team
May 5, 2010Medical Communications Virgo, appointment, medical communications
Virgo Health has expanded its medical education offering, appointing Katherine Mantell and Adam Pittard. Katherine joins the agency as editorial …
More quality issues dog J&J
May 5, 2010Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls
Johnson & Johnson’s manufacturing is under the spotlight at the FDA once again for quality issues affecting its products. At …
Oxford BioMedica hopes vaccine first will raise interest
May 5, 2010Sales and Marketing Dendreon, Oxford BioMedica, Provenge, TroVax
Oxford BioMedica is hoping that the approval of the world’s first immunotherapy cancer vaccine in the US will help it …
BMS on tenterhooks over belatacept future
May 4, 2010Research and Development BMS, belatacept
Bristol-Myers Squibb has been kept on tenterhooks by US regulator the FDA over the future of its investigational kidney transplant …
Pfizer still at number 1, but Lipitor to slip
May 4, 2010Sales and Marketing Humira, Lipitor, Pfizer, sales
New research suggests that the pharma world is going to be shaken up over the next few years – although …
Sanofi’s chief strategic officer to step down
May 4, 2010Sales and Marketing Sanofi-Aventis, appointment, sales and marketing
Laurence Debroux, chief strategic officer at Sanofi-Aventis, is to leave the company at the end of June. The company said …
Chiltern Wins Award at the Inaugural US Pharma Awards Ceremony
May 4, 2010Research and Development
Glenn Kerkhof, Chiltern CEO, congratulated Kim Todd, Chiltern’s Silver Medal Award Winner in the category of experienced Clinical Research Associate/Site …
EU votes for tighter internet drug regulations
May 4, 2010Sales and Marketing EU, counterfeits, viagra
The European Parliament has voted to enact stronger legislation against poor quality medicines available on the internet. The move comes …
Staff cuts already planned, warns nurses’ leader
May 4, 2010NHS trusts, election, general election, nurses
The leader of nurses in the UK has warned that NHS trusts around the country are already planning significant job …
Contract research news in brief
May 4, 2010Research and Development Corealis, Norwich Pharma, PPD, PRA, biofocus
Our round-up of developments in the contract research sector includes a new $41m contract for BioFocus, new locations for PPD, …
Evotec wins grant to advance H3 receptor antagonist
May 4, 2010Research and Development CNS, Evotec, MS
Evotec is to receive funding of up to 1.5 million euros from a German government fund to advance its H3 …
Digital Pharma: Bayer expands InBed ED campaign
April 30, 2010Medical Communications Bayer Schering Pharma, digital pharma, disease awareness campaigns, erectile dysfunction
Bayer Schering Pharma has launched a Spanish version of its InBed erectile dysfunction disease awareness campaign. Under the tagline ‘en la …
Colorcon buys French excipients specialist
April 30, 2010Manufacturing and Production Colorcon, Ethypharm, NP Pharm, contract manufacturing, excipients
US-based Colorcon has acquired excipient specialist NP Pharm, a division of French drugmaker Ethypharm, in order to expand its product portfolio …
Shire revenue dips after generic Adderall hit
April 30, 2010Sales and Marketing Adderall, Fabrazyme, Gaucher's, Shire
Shire’s first quarter revenues fell by 5% after its ADHD treatment Adderall XR succumbed to generic competition from Teva. This …
FDA warns Teva over California plant
April 30, 2010Manufacturing and Production Teva, manufacturing compliance
Teva has become the latest drugmaker to be rebuked by the FDA for not responding effectively enough to compliance problems …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
